Trial offers hope for new revaccination strategies with Bacille Calmette-Guerin (BCG) against Tuberculosis, the world's leading infectious disease killer

Drug extends survival, reverses some neuromuscular damage in animals

The results reveal that tumors are much more complex than previously appreciated

NIPD can reduce the number of procedure-related miscarriages

The quantitative suspension array assays developed by ISGlobal researchers could simplify sero-epidemiological studies and vaccine development

Sepsis is an infection that kills as many Americans each year as stroke and Alzheimer's combined

Acoustic microfluidic platform gently and quickly separates circulating tumor cells from blood samples

EMBL scientists investigate how influenza virus responds to new drug treatment

Navigate rapidly changing landscape of infectious diseases tests, enabling faster, better treatment

Together, the companies will leverage expertise in genomics and molecular information to enhance the development of personalized medicines and care for patients with cancer

New computational method integrates multiple molecular data types to study the variability between patients in complex diseases

The discovery paves the way for developing personalized medicine approaches to target this previously unnoticed form of the disease